Invention Grant
US08962843B2 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
有权
1,3,4-噻二唑和β-内酰胺酶抑制剂
- Patent Title: 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
- Patent Title (中): 1,3,4-噻二唑和β-内酰胺酶抑制剂
-
Application No.: US13853327Application Date: 2013-03-29
-
Publication No.: US08962843B2Publication Date: 2015-02-24
- Inventor: Yu Gui Gu , Yong He , Ning Yin , Dylan C. Alexander , Jason B. Cross , Chester A. Metcalf, III
- Applicant: Cubist Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Cubist Pharmaceuticals, Inc.
- Current Assignee: Cubist Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Lathrop & Gage LLP
- Agent Brian C. Trinque
- Main IPC: C07D471/08
- IPC: C07D471/08 ; A61K31/546 ; A61K31/439 ; A61K31/545 ; A61K31/407 ; A61K45/06 ; A61K31/436 ; A61K31/427
Abstract:
β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
Public/Granted literature
- US20130296290A1 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS Public/Granted day:2013-11-07
Information query
